AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19

Published by

By Ludwig Burger and Sachin Ravikumar (Reuters) -AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system. In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77%. The antibody therapy called AZD7442 could protect people who do not have a strong enough immune response to COVID…

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *